Equities
Health CareHealth Care Providers
  • Price (USD)221.55
  • Today's Change-7.03 / -3.08%
  • Shares traded1.45m
  • 1 Year change-23.62%
  • Beta0.5595
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.

  • Revenue in USD (TTM)41.87bn
  • Net income in USD1.18bn
  • Incorporated2002
  • Employees18.00k
  • Location
    Molina Healthcare Inc200 Oceangate, Suite 100LONG BEACH 90802-4317United StatesUSA
  • Phone+1 (562) 435-3666
  • Fax+1 (302) 636-5454
  • Websitehttps://www.molinahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MOH:NYQ since
announced
Transaction
value
ConnectiCare Holding CoDeal completed23 Jul 202423 Jul 2024Deal completed-23.50%350.00m
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chemed Corp2.49bn308.74m6.73bn15.70k22.405.6718.092.7020.5320.53165.4781.091.44175.3710.75158,585.3017.8819.2021.4324.0534.8235.2012.4012.781.70--0.00048.197.374.6310.826.55-1.357.74
Ensign Group Inc4.42bn309.42m8.28bn39.30k27.174.3020.771.875.305.3075.7633.480.9756--8.02112,553.506.836.668.118.1121.3222.307.006.87----0.06975.6514.2415.9142.3026.58-5.784.78
Hims & Hers Health Inc1.78bn164.40m10.72bn1.64k70.0319.4957.376.010.68390.68397.402.462.667.73267.341,090,014.0024.54-3.9134.03-4.7477.04--9.21-2.351.32--0.00--69.33--635.28155.96----
Davita Inc12.97bn859.61m10.76bn76.00k14.11--5.690.829910.1010.10152.64-3.460.750759.125.28170,638.506.816.099.268.0632.4631.219.088.691.204.050.8544--5.562.3935.405.82-6.24--
Universal Health Services Inc16.08bn1.20bn11.76bn86.00k10.251.736.490.731317.8117.81239.04105.301.11--6.83187,024.108.436.6810.017.94----7.586.621.239.840.40315.6310.826.8259.177.047.565.92
Encompass Health Corp5.51bn494.00m11.96bn23.56k24.485.5212.392.174.844.8253.9921.440.8565--8.87233,941.6010.206.7213.268.3995.6095.4111.919.53--7.090.45726.0411.913.1326.024.949.72-10.27
Molina Healthcare Inc41.87bn1.18bn12.01bn18.00k10.702.788.800.286820.7020.70737.0879.812.62--12.242,325,889.007.377.3015.4415.9615.2215.662.812.86--12.810.46630.0019.3119.298.079.8511.90--
Centene Corp169.28bn3.45bn15.64bn60.50k4.680.56033.330.09246.726.72329.5556.112.00--8.622,798,083.004.072.796.934.4210.2711.272.041.48--5.260.39540.005.8916.9222.3220.13-2.48--
Tenet Healthcare Corp20.52bn1.46bn16.32bn74.48k11.623.905.150.795515.1215.12212.6045.010.70589.816.66275,510.208.096.3211.888.9882.3382.7511.468.841.706.080.60350.000.56942.26423.73--6.80--
Data as of Jul 11 2025. Currency figures normalised to Molina Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

55.66%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20256.22m11.20%
Capital Research & Management Co. (World Investors)as of 31 Mar 20255.29m9.54%
T. Rowe Price Associates, Inc. (IM)as of 31 Mar 20253.75m6.76%
BlackRock Fund Advisorsas of 31 Mar 20253.20m5.77%
Capital Research & Management Co. (Global Investors)as of 31 Mar 20252.90m5.22%
SSgA Funds Management, Inc.as of 31 Mar 20252.49m4.49%
Fidelity Management & Research Co. LLCas of 31 Mar 20252.24m4.04%
Wellington Management Co. LLPas of 31 Mar 20251.67m3.00%
Capital Research & Management Co. (International Investors)as of 31 Mar 20251.61m2.90%
Geode Capital Management LLCas of 31 Mar 20251.52m2.74%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.